{"organizations": [], "uuid": "8464e13b6199291a6ef9e15f8e0ed335e17801d3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-gilead-and-verily-announce-scienti/brief-gilead-and-verily-announce-scientific-collaboration-idUSFWN1S71C7", "country": "US", "domain_rank": 408, "title": "BRIEF-Gilead And Verily Announce Scientific Collaboration", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-30T23:43:00.000+03:00", "replies_count": 0, "uuid": "8464e13b6199291a6ef9e15f8e0ed335e17801d3"}, "author": "", "url": "https://www.reuters.com/article/brief-gilead-and-verily-announce-scienti/brief-gilead-and-verily-announce-scientific-collaboration-idUSFWN1S71C7", "ord_in_thread": 0, "title": "BRIEF-Gilead And Verily Announce Scientific Collaboration", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "gilead sciences inc", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "gilead sciences inc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "gilead", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 30 (Reuters) - Gilead Sciences Inc:\n* GILEAD AND VERILY ANNOUNCE SCIENTIFIC COLLABORATION TO IDENTIFY AND UNDERSTAND IMMUNOLOGICAL AND MOLECULAR DRIVERS OF INFLAMMATORY DISEASES\n* GILEAD SCIENCES INC - VERILY TO DEPLOY ITS IMMUNOSCAPE PLATFORM TO GENERATE INSIGHTS FROM GILEAD CLINICAL TRIALS\n* GILEAD SCIENCES INC - THREE-YEAR COLLABORATION WITH VERILY LIFE SCIENCES Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": [], "published": "2018-04-30T23:43:00.000+03:00", "crawled": "2018-05-01T00:02:22.006+03:00", "highlightTitle": ""}